Resource for groundbreaking clinical and basic research in the disciplines of immunopharmacology and immunotoxicology, furnishing original scientific papers, brief communications and reviews on the alterations of the immune system and other relevant topics such as the disease-mediating capacity of immunomodulating agents. Features experimental and clinical results on cytokines and chemokines, vaccines, nutrition and neuroimmunopharmacology. Provides coverage on immunomodifying agents to treat diseases such as cancer, immunodeficiency, chronic infection, allergy, and inflammatory and autoimmune disorders, and the adverse or positive effects of xenobiotics on the immune system, including chemicals, metals, food additives and airborne pollutants.

The journal aims to deliver essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research.Content:Articles published in Immunotherapy include key areas such as: Cancer immunotherapy, including cancer vaccines and passive immunotherapeutic approaches Combined chemo/radioimmunotherapy in cancer treatment Restorative immunotherapy for AIDS and other immunocompromised patients Suppressive immunotherapy for autoimmunity diseases and transplantation Basic science of immunotherapeutic approaches Drug–immune system interactions Drug delivery systems, drug combinations and drug-drug interactions Summaries evaluating newly approved immunotherapeutic agents Newly identified immune targets of drugs Results of recent findings and clinical trials relevant to the field of immunotherapy Postmarketing research, including adverce events, drug safety, pharmacoeconomics and cost–benefit issuesEditorial contacts:A full list of editorial contacts can be found hereManuscript Submission:Author guidelines can be viewed at here.Online manuscript submission can be found here.Ad Rates:Further information on ad rates can be found here.

Written for scientists and research institutions involved in immunotherapy. Editorial mission is to provide insight into the immunologic bases of diseases and immune system dysfunctions, while emphasizing biological agents and biotechnology. Topics include vaccines, gene therapy, immunoconjugates, cancer biotechnology, monoclonal antibodies, cytokines and immunomodulators. NewsRX™ is a digital news, publishing technology and IT company and uses an automated article writing and periodical production software platform (Artificial Intelligence Journalist – AIJ) producing 35,000 unique articles weekly and 195 autocreated digital newsweeklies. Artificial Intelligence Journalist™ (“AIJ”) and Artificial Intelligence Editor™ (“AIE”), is a proprietary software technology which automates every aspect of publishing, from writing and editing to distribution and analytics.

iMoneyNet provides yields, assets, average maturities and portfolio composition statistics for more than 1,800 money-market mutual funds, as well as category averages and insightful commentary.

Written for iPhone, iPod and iPad users. Features news, information, reviews, tips and tricks. The fundamentals of working with bloggers are the same as with traditional journalists at traditional media outlets: respect their schedules; take time to read their material to learn their interests; and only contact them if/when they want to be contacted. You will also find that if a blogger is a journalist for another outlet(s), Cision tracks their contact preferences there as well. The outlet offers RSS (Really Simple Syndication). PR opportunities are available for reviews, news items, brand name or product placement, competitions and possibly interviews. The team can be reached via the email above. To specifically submit an iOS app for review, email iosapps@imore.com.

iMore show is a tech podcast. A podcast is a downloadable video or audio broadcast show. Most podcasts are available by subscription through an RSS reader or other aggregator. The fundamentals of working with podcasters are the same as with traditional journalists at traditional media outlets: respect their schedules; take time to watch or listen to their material to learn their interests, format of content; and only contact them if relevant.

Background and Format: Relaunched as Impact magazine in April 2013. It explores how insights and evidence are used to shape business and policy. Impact is published by the Market Research Society (MRS). Formerly Research , a monthly magazine for the international market research industry, with news coverage, and analysis for research buyers and providers. The publication is supported by and can also be found via the www.research-live.com website, but it contains largely unique content that is not published online. It is aimed at senior decision makers in any organisation - suppliers, buyers and users of data, evidence and market and social research. The editorial deadlines vary, but the magazine goes to press around 21st / 22nd of the month before publication. It is published in April, July, October, January. The magazine DOES accept byline articles, however they prefer to receive a synopsis first. These usually end up online rather than in the magazine. Press enquiries can be sent to the Editor at jane.bainbridge@mrs.org.uk. For ad rates contact guy.oliver@mrs.org.uk Circulation: Source: Publisher Alerts: Gorkana Alert: Tuesday 30 April 2013 The Market Research Society (MRS) has launched Impact, a new quarterly magazine for the market research sector which explores how insights and evidence are used to shape business and policy. Impact replaces the monthly print magazine Research which is now digital-only and can be viewed at www.research-live.com. For editorial enquiries and feedback on both titles, Editor Brian Tarran can be reached on +44 (0)20 7566 1864 and brian.tarran@mrs.org.uk

Aimed at government offices, top international foundations, corporate partners, policy makers in the U.S., Europe and the developing world, thought leaders, target media and public health officials. This publication is supported by Population Services International (PSI), a global non-profit organization dedicated to improving the health of people in the developing world by focusing on serious challenges like a lack of family planning, HIV/AIDS, barriers to maternal health, and the greatest threats to children under five, including malaria, diarrhea, pneumonia and malnutrition.

Published for the alcohol and beverage industry, and reports global news and research pertaining to the field. Written for industry executives, beverage suppliers, and wholesalers.

Written for members of the Public Affairs Council, including corporations, associations, consulting firms and their employees. Covers news on corporate public affairs, government relations and politics.